久久精品高清视频_久久久久国产成人精品亚洲午夜_免费日本一区_久久久久久穴

推廣 熱搜:   血戰(zhàn)麻將群  一元一分  品牌  麻將  昆山    梯子游戲  冰球突破  加工廠 

TCR activator / PD-L1 - CHO

點(diǎn)擊圖片查看原圖
  • 發(fā)布日期:2024-01-29 10:17
  • 有效期至:長(zhǎng)期有效
  • 商機(jī)區(qū)域:全國(guó)
  • 瀏覽次數(shù)2
  • 留言咨詢
詳細(xì)說明
TCR activator / PD-L1 - CHO Recombinant Cell line

Recombinant CHO-K1 cells constitutively expressing human PD-L1 (Programmed Cell Death 1 Ligand 1, CD274, B7 homolog 1 (B7- H1), GenBank accession # NM_014143) and an engineered T cell receptor (TCR) activator. This cell lines was functionally validated in a cell-based assay.

Figure 1: Mechanism of action of TCR activator/ PD-L1 CHO Cell Line in combination with PD-1/NFAT reporter-Jurkat cell line. Jurkat T cells expressing NFAT reporter with constitutive expression of PD-1 (PD-1/NFAT Reporter Jurkat Cell Line, BPS Bioscience #60535) act as effector cells. When co-c*ted, TCR complexes on PD-1/NFAT Reporter Jurkat cells are activated by the TCR activator of TCR Activator/ PD-L1– CHO Recombinant Cell Line, resulting in expression of the NFAT luciferase reporter. 

However, PD-1 and PD-L1 ligation prevents TCR activation and suppresses the NFAT-responsive luciferase activity. This inhibition can be specifically reversed by anti-mouse PD-1 or anti-mouse PD-L1 antibodies. PD-1/PD-L1 neutralizing antibodies block PD-1:PD-L1 interaction and promote T cell activation, resulting in reactivation of the NFAT responsive luciferase reporter.

更多詳情:http://www.bpsbioscience.com.cn/Products-37982681.html
https://www.chem17.com/st542058/product_37982681.html
原文鏈接:http://www.525682.com/shangji/show-19917.html,轉(zhuǎn)載和復(fù)制請(qǐng)保留此鏈接。
以上就是關(guān)于TCR activator / PD-L1 - CHO全部的內(nèi)容,關(guān)注我們,帶您了解更多相關(guān)內(nèi)容。
0相關(guān)評(píng)論
聯(lián)系方式
該企業(yè)最新商機(jī)
網(wǎng)站首頁  |  VIP套餐介紹  |  關(guān)于我們  |  聯(lián)系方式  |  手機(jī)版  |  版權(quán)隱私  |  SITEMAPS  |  網(wǎng)站地圖  |  排名推廣  |  廣告服務(wù)  |  積分換禮  |  網(wǎng)站留言  |  RSS訂閱  |  違規(guī)舉報(bào)